Medical News: FDA Okays First Drug for Hormone-Refractory Prostate Cancer - in Product Alert, Prescriptions from MedPage Today

Links shared publicly online about this topic.

  • 1,087
    total visits

Medical News: FDA Okays First Drug for Hormone-Refractory Prostate Cancer - in Product Alert, Prescriptions from MedPage Today

medpagetoday.com —

WASHINGTON -- The FDA has approved the chemotherapy agent cabazitaxel (Jevtana) to be used in conjunction with the steroid prednisone for treatment of hormone-refractory prostate cancer.

View full resource at medpagetoday.com

Tags: Cancer, Chemotherapy, Prostate Cancer, Prostate, Drug, Men's Health, FDA, Prednisone

  • Share

Most Recently Shared on June 18, 2010 at 2:01 am By:

RMEOncology ReedMedicalEducation

RT @CME_Meetings: News: FDA Okays First Drug for Hormone-Refractory Prostate Cancer http://ow.ly/17MBmE

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

FightCancer FightCancer

Advertisement